SB INVESTMENT ADVISERS (UK) LTD

Holdings History for Roivant Sciences Ltd. - COMMON STOCK (ROIV)

Symbol: ROIV on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Shares Owned: 16,413,603 shares
Security Ownership %: 2.3%

Shares, Excluding Options vs Price

Value, Excluding Options

SB Investment Advisers (UK) Limited ownership in Roivant Sciences Ltd. COMMON STOCK (ROIV)

17 Feb 2026 - SB Investment Advisers (UK) Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 16,413,603 shares of Roivant Sciences Ltd. COMMON STOCK (ROIV). This represents 2.3% ownership of the company. In their previous filing dated 14 Nov 2025, SB INVESTMENT ADVISERS (UK) LTD had reported owning 40,315,127 shares, indicating a decrease of +59%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
SB Investment Advisers (UK) Limited	2.3%	-58%	$357,488,273	16,413,603	-23,901,524	-59%	$21.78	13G/A	31 Dec 2025	17 Feb 2026, 17:00
SB Investment Advisers (UK) Limited	5.8%	-30%	$609,967,872	40,315,127	-21,742,410	-35%	$15.13	13G/A	30 Sep 2025	14 Nov 2025, 16:30
SB Investment Advisers (UK) Limited	8.5%		$683,253,482	62,057,537			$11.01	13G/A	31 Dec 2024	14 Feb 2025, 09:59

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	3.6%	-5.2%	$356,175,185	16,413,603	-23,901,524	-59%	$21.70	Q4 2025
30 Sep 2025	4.6%	-2.2%	$609,967,872	40,315,127	-19,637,525	-33%	$15.13	Q3 2025
30 Jun 2025	5.4%	-0.17%	$675,666,388	59,952,652	-1,900,066	-3.1%	$11.27	Q2 2025
31 Mar 2025	5.7%	-0.02%	$624,093,925	61,852,718	-204,819		$10.09	Q1 2025
31 Dec 2024	6.4%	-0.4%	$734,140,663	62,057,537	-3,876,537	-5.9%	$11.83	Q4 2024
30 Sep 2024	6.3%	-0.52%	$760,879,214	65,934,074	-5,427,314	-7.6%	$11.54	Q3 2024
30 Jun 2024	7%	-0.17%	$754,289,871	71,361,388	-1,670,279	-2.3%	$10.57	Q2 2024
31 Mar 2024	7.6%	0%	$769,753,770	73,031,667	0		$10.54	Q1 2024
31 Dec 2023	7.3%	0%	$820,145,620	73,031,667	0		$11.23	Q4 2023
30 Sep 2023	7%	-0.96%	$853,009,871	73,031,667	-10,000,000	-12%	$11.68	Q3 2023
30 Jun 2023	6.4%	0%	$836,959,203	83,031,667	0		$10.08	Q2 2023
31 Mar 2023	5%	-0.73%	$612,773,702	83,031,667	-12,000,000	-13%	$7.38	Q1 2023
31 Dec 2022	6.3%	-0.29%	$759,303,019	95,031,667	-4,343,919	-4.4%	$7.99	Q4 2022
30 Sep 2022	2.4%	0%	$319,989,000	99,375,586	0		$3.22	Q3 2022
30 Jun 2022	3.2%	0%	$404,459,000	99,375,586	0		$4.07	Q2 2022
31 Mar 2022	2.3%	0%	$490,915,000	99,375,586	0		$4.94	Q1 2022
31 Dec 2021	2.9%	+2.9%	$1,001,706,000	99,375,586	+99,375,586	NEW	$10.08	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.